Neuralgia treatment involves addressing a medical condition characterized by persistent nerve-related pain, which can result from injury, infection, or underlying medical issues. This treatment aims to effectively manage symptoms, slow the progression of neuralgia, and prevent potential complications.
Neuralgia treatment primarily falls into two categories drug-based therapies and surgical interventions. Drug-based treatment involves the use of medications to manage, alleviate, or even cure various medical conditions and diseases, including diabetic neuropathy, intercostal neuralgia, occipital neuralgia, peripheral neuralgia, and postherpetic neuralgia. These medications are accessible through various distribution channels such as drug stores, hospital pharmacies, online pharmacies, and retail pharmacies. They are utilized in diverse healthcare settings, including hospitals, clinics, ambulatory surgery centers, and other medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The neuralgia treatment market research report is one of a series of new reports from The Business Research Company that provides neuralgia treatment market statistics, including neuralgia treatment industry global market size, regional shares, competitors with a neuralgia treatment market share, detailed neuralgia treatment market segments, market trends and opportunities and any further data you may need to thrive in the neuralgia treatment industry. This neuralgia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neuralgia treatment market size has grown strongly in recent years. It will grow from $2.3 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising prevalence of neuralgia, neuropathic pain awareness, rise in chronic pain conditions, presence of high disposable income, government initiatives.
The neuralgia treatment market size is expected to see strong growth in the next few years. It will grow to $3.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to aging population, emerging therapies, increasing incidences of diabetes, high healthcare expenditure. Major trends in the forecast period include advancements in pain management, innovative products, digital health integration, development of new drug delivery systems.
The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. pain clinics by driving up the cost of high-frequency spinal cord stimulators and anticonvulsant medications sourced from the UK and India, exacerbating chronic pain management challenges and raising neurology department budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of chronic diseases, such as diabetes, is expected to drive the expansion of the neuralgia treatment market. Chronic diseases are long-term conditions that require ongoing medical care, limit daily activities, or both. Diabetes, a metabolic disorder marked by elevated blood glucose levels, is one such condition. Neuralgia treatments can help manage diabetic neuropathy, a type of nerve damage commonly seen in individuals with diabetes. For example, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that 41 million deaths, or 74% of those caused by non-communicable diseases (NCDs), occur globally each year. As a result, the increasing prevalence of chronic diseases, including diabetes, is fueling the growth of the neuralgia treatment market.
The expected rise in the number of surgical procedures is anticipated to drive the growth of the neuralgia treatment market. Surgical procedures involve medical interventions that either require incisions or utilize minimally invasive techniques to access and treat tissues or organs within the body. These procedures contribute to the expansion of the neuralgia treatment market by providing options for patients when non-surgical treatments are ineffective or when a specific anatomical issue can be surgically addressed. For example, in February 2024, the National Healthcare Statistics, a US-based government agency, reported that cataract surgery was the most commonly performed procedure in 2022, with 39,347 cases, 98.3% of which were day cases. This was followed by 20,537 caesarean sections and 12,830 hip replacements, most of which were inpatient procedures. Thus, the increasing number of surgical procedures is expected to drive the growth of the neuralgia treatment market.
Major players in the neuralgia treatment market are dedicated to the development of cutting-edge products and solutions to maintain their competitive edge in the industry. As an illustration, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Shingrix, the world's first non-live recombinant subunit vaccine. This vaccine is specifically designed to prevent shingles and post-herpetic neuralgia in adults aged 50 years and above, administered intramuscularly in two doses. Shingrix leverages the antigen glycoprotein E along with the adjuvant system AS01B to generate a potent and long-lasting immune response, countering age-related immune system deterioration. Clinical trials have demonstrated its remarkable 97% effectiveness in preventing shingles in adults, while also effectively guarding against post-herpetic neuralgia, a painful complication of shingles.
In November 2022, Kriya Therapeutics Inc., a gene therapy company based in the United States, completed the acquisition of Redpin Therapeutics Inc. The specific financial details of the transaction were not disclosed. This strategic acquisition is poised to enhance Kriya Therapeutics Inc.'s gene therapy portfolio for addressing neurological disorders, encompassing conditions like epilepsy, trigeminal neuralgia, and Parkinson's disease. Redpin Therapeutics Inc., also based in the United States, is a biotechnology company with a strong track record in effectively treating a range of neurological disorders, including neuralgia.
Major companies operating in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals.
North America was the largest region in the neuralgia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neuralgia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neuralgia treatment market consists of revenues earned by entities by providing blood tests, magnetic resonance imaging (MRI), nerve conduction velocity tests, physical therapies and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuralgia treatment market also includes sales of anticonvulsant medications, pain relievers, antidepressants and antiseizure medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neuralgia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neuralgia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neuralgia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuralgia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Drug Based; Surgeries
- 2) By Indication: Diabetic Neuropathy; Intercostal Neuralgia; Occipital Neuralgia; Peripheral Neuralgia; Postherpetic Neuralgia
- 3) By Distribution channels: Drug Stores; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
- 4) By End-Use: Hospitals And Clinics; Ambulatory Surgery Centers; Other End-Users
- Subsegments:
- 1) By Drug Based: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- 2) By Surgeries: Nerve Block Procedures; Decompression Surgery; Neurectomy; Spinal Cord Stimulation
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Eli Lilly and Company; Gilead Sciences Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Astellas Pharma Inc.; Biogen Inc.; Daiichi Sankyo Company Limited; Boehringer Ingelheim International GmbH; Sun Pharmaceutical Industries Limited; Horizon Therapeutics; Purdue Pharma; Dr. Reddy's Laboratories; Cipla Limited; Hikma Pharmaceuticals plc; Zydus Lifesciences Ltd.; Lupin Limited; Mallinckrodt Pharmaceuticals; Glenmark Pharmaceuticals; Tonix Pharmaceuticals
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neuralgia Treatment Market Characteristics
3. Neuralgia Treatment Market Trends And Strategies
4. Neuralgia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Neuralgia Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Neuralgia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Neuralgia Treatment Market Growth Rate Analysis
- 5.4. Global Neuralgia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Neuralgia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Neuralgia Treatment Total Addressable Market (TAM)
6. Neuralgia Treatment Market Segmentation
- 6.1. Global Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Based
- Surgeries
- 6.2. Global Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diabetic Neuropathy
- Intercostal Neuralgia
- Occipital Neuralgia
- Peripheral Neuralgia
- Postherpetic Neuralgia
- 6.3. Global Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Stores
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- 6.4. Global Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Ambulatory Surgery Centers
- Other End-Users
- 6.5. Global Neuralgia Treatment Market, Sub-Segmentation Of Drug Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anticonvulsants
- Antidepressants
- Opioids
- Topical Treatments
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- 6.6. Global Neuralgia Treatment Market, Sub-Segmentation Of Surgeries, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nerve Block Procedures
- Decompression Surgery
- Neurectomy
- Spinal Cord Stimulation
7. Neuralgia Treatment Market Regional And Country Analysis
- 7.1. Global Neuralgia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Neuralgia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neuralgia Treatment Market
- 8.1. Asia-Pacific Neuralgia Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neuralgia Treatment Market
- 9.1. China Neuralgia Treatment Market Overview
- 9.2. China Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neuralgia Treatment Market
- 10.1. India Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neuralgia Treatment Market
- 11.1. Japan Neuralgia Treatment Market Overview
- 11.2. Japan Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neuralgia Treatment Market
- 12.1. Australia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neuralgia Treatment Market
- 13.1. Indonesia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neuralgia Treatment Market
- 14.1. South Korea Neuralgia Treatment Market Overview
- 14.2. South Korea Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neuralgia Treatment Market
- 15.1. Western Europe Neuralgia Treatment Market Overview
- 15.2. Western Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neuralgia Treatment Market
- 16.1. UK Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neuralgia Treatment Market
- 17.1. Germany Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neuralgia Treatment Market
- 18.1. France Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neuralgia Treatment Market
- 19.1. Italy Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neuralgia Treatment Market
- 20.1. Spain Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neuralgia Treatment Market
- 21.1. Eastern Europe Neuralgia Treatment Market Overview
- 21.2. Eastern Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neuralgia Treatment Market
- 22.1. Russia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neuralgia Treatment Market
- 23.1. North America Neuralgia Treatment Market Overview
- 23.2. North America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neuralgia Treatment Market
- 24.1. USA Neuralgia Treatment Market Overview
- 24.2. USA Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neuralgia Treatment Market
- 25.1. Canada Neuralgia Treatment Market Overview
- 25.2. Canada Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neuralgia Treatment Market
- 26.1. South America Neuralgia Treatment Market Overview
- 26.2. South America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neuralgia Treatment Market
- 27.1. Brazil Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neuralgia Treatment Market
- 28.1. Middle East Neuralgia Treatment Market Overview
- 28.2. Middle East Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neuralgia Treatment Market
- 29.1. Africa Neuralgia Treatment Market Overview
- 29.2. Africa Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Neuralgia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neuralgia Treatment Market Competitive Landscape And Company Profiles
- 30.1. Neuralgia Treatment Market Competitive Landscape
- 30.2. Neuralgia Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Neuralgia Treatment Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Bristol-Myers Squibb Company
- 31.3. AstraZeneca plc
- 31.4. Abbott Laboratories
- 31.5. GlaxoSmithKline plc
- 31.6. Eli Lilly and Company
- 31.7. Gilead Sciences Inc.
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Mylan N.V.
- 31.10. Astellas Pharma Inc.
- 31.11. Biogen Inc.
- 31.12. Daiichi Sankyo Company Limited
- 31.13. Boehringer Ingelheim International GmbH
- 31.14. Sun Pharmaceutical Industries Limited
- 31.15. Horizon Therapeutics
32. Global Neuralgia Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neuralgia Treatment Market
34. Recent Developments In The Neuralgia Treatment Market
35. Neuralgia Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Neuralgia Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Neuralgia Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Neuralgia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
